Stage II Bladder Cancer

10 clinical trials · Condition

Record	Firm	Date
Ask Questions (ASQ):Implementation of a Communication Intervention (NCT05025748)	Barbara Ann Karmanos Cancer Institute	2021-08-25
MDSC Clinical Assay in Finding and Monitoring Cancer Cells in Blood and Urine Samples From Patients With or Without Localized or Metastatic Bladder Cancer (NCT02735512)	University of Southern California	2016-03-01
Urinary Diversion During Robotic Assisted Radical Cystectomy in Patients With Bladder Cancer (NCT02252393)	Case Comprehensive Cancer Center	2015-10-01
Family Caregiver Palliative Care Intervention in Supporting Caregivers of Patients With Stage II-IV Gastrointestinal, Gynecologic, Urologic and Lung Cancers (NCT01846520)	City of Hope Medical Center	2013-10-01
Sirolimus, Cisplatin, and Gemcitabine Hydrochloride in Treating Patients With Bladder Cancer (NCT01938573)	University of Washington	2013-10-01
Gemcitabine Hydrochloride and Cisplatin Before Surgery in Treating Patients With Muscle Invasive Bladder Cancer (NCT01611662)	Fox Chase Cancer Center	2012-05-29
Broccoli Sprout Extract in Treating Patients With Transitional Cell Bladder Cancer Undergoing Surgery (NCT01108003)	Roswell Park Cancer Institute	2010-04-01
Green Tea Extract in Treating Patients With Nonmetastatic Bladder Cancer (NCT00666562)	National Cancer Institute (NCI)	2008-07-02
Neoadjuvant Intravesical Vaccine Therapy in Treating Patients With Bladder Carcinoma Who Are Undergoing Cystectomy (NCT00072137)	National Cancer Institute (NCI)	2003-10-01
Gene Therapy in Treating Patients With Advanced Bladder Cancer (NCT00003167)	National Cancer Institute (NCI)	1998-05-01

Track Stage II Bladder Cancer automatically

Every clearance here is in the API, with alerts when new ones post.